February 1, 2024
Chuikyo General Assembly Meeting on January 31 Japan’s Ministry of Health, Labor and Welfare (MHLW) plans to introduce a new reimbursement premium for the use of biosimilars in inpatient care under the FY2024 medical fee reform, covering a total of...read more